Kaposi Sarcoma

Jae Jung, PhD, has been appointed chair of Cleveland Clinic Lerner Research Institute’s department of cancer biology.

The FDA granted accelerated approval to pomalidomide for treatment of two forms of Kaposi sarcoma.

Low-dose pomalidomide was well-tolerated and helped clear high-grade squamous intraepithelial lesions caused by HPV in patients with and without HIV, according to research from the Conference on Retroviruses and Opportunistic Infections.

Infectious Disease News Chief Medical Editor Paul A. Volberding, MD, spoke with Healio about which types of cancer patients with HIV are more likely to develop, how HIV treatments have changed that risk, how cancer affects HIV treatment and how to increase cancer treatment among these patients.